ArticleMicrobiology spectrum2022
Escherichia marmotae-a Human Pathogen Easily Misidentified as Escherichia coli.
Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Characterization of the intrinsic AmpC β-lactamase of Escherichia marmotae and its impact on decreased susceptibility to cefiderocol and resistance to broad-spectrum cephalosporins.The Journal of antimicrobial chemotherapy · 2026Article
- Using Ongoing Wildlife Surveillance Programs to Monitor Antibiotic Resistant Bacteria in the Environment.Environmental microbiology reports · 2026Article
- Draft genomes of twoMicrobiology resource announcements · 2026Article
- From Cryptic Clade to Emerging Pathogen: Exploring the Evolutionary Divergence and Clinical Relevance ofMicroorganisms · 2026Review
- Article
- Antibiotic Resistance Profiles of Commensal and Pathogenic Bacteria Isolated from Wild Boar Carcasses in Campania Region, Southern Italy.Antibiotics (Basel, Switzerland) · 2026Article
- Global genomic insights into the antimicrobial resistance ofZoological research · 2025Article
- ImprovedMicrobial genomics · 2025Article
- Carbapenem resistance in Escherichia marmotae: characterization of IncL plasmids carrying blaOXA-48.The Journal of antimicrobial chemotherapy · 2025Article
- Whole-genome characterization and antibiotic resistance phenotype ofMicrobiology spectrum · 2025Article
- Moraxella marmotae sp. nov. Isolated from the Respiratory Tract of Marmota himalayana.Current microbiology · 2025Article
- Genomic Features of E. ruysiae Associated with the Ecological Origin: Implications for the Environmental Hypothesis.Current microbiology · 2025Article
- Complete genome sequence ofMicrobiology resource announcements · 2025Article
- Pathogenic bacterial taxa constitute a substantial portion of fecal microbiota in common migratory bats and birds in Europe.Microbiology spectrum · 2025Article
- New diagnostic methods forFrontiers in microbiology · 2025Article
- Genome organization, virulence genes, and temperature-dependent motility of an emerging pathogen,Frontiers in microbiology · 2025Article
- Impact of land-use and fecal contamination on Escherichia populations in environmental samples.Scientific reports · 2024Article
- Genomic Characterization and Comparative Analysis of Streptococcus zhangguiae sp. nov. Isolated from the Respiratory Tract of Marmota Himalayana.Journal of microbiology (Seoul, Korea) · 2024Article
- Genomic dissection ofISME communications · 2024Article
- Molecular characterization of highly prevalentMicrobiology spectrum · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We hereby present the first descriptions of human-invasive infections caused by Escherichia marmotae, a recently described species that encompasses the former
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.